NEWS & PRESS RELEASES

BioFluidica Co-Founder Named to National Academy of Inventors
Biofluidica, Inc. Co-Founder Steven Soper has been named to the National Academy of Inventors for the third year in a…
READ MORE
BioFluidica to Exhibit at AACR National Meeting, San Diego, CA ~ April 5 – 10, 2024
This year Biofluidica will be exhibiting at AACR (booth #953). If you have any interest in exosomes as biomarkers this…
READ MORE
BioFluidica Showcased Fetal Cell-Based DNA Test at #SMFM2024
BioFluidica, Inc. will be showcased their Fetal Cell-Based DNA Test (in development) at #SMFM2024 from Feb 11-14th! Visitors came to Booth…
READ MORE
BioFluidica Exhibits at SITC, November 3 – 5
Biofluidica exhibited in San Diego November 1-5 at the Society for Immunotherapy of Cancer’s 39th Annual Meeting. Many researchers stopped…
READ MORE
BioFluidica to Launch Prenatal Blood Screening Study
BioFluidica is currently seeking pregnant women aged 18 years and older in the early stages of pregnancy, specifically between 7-13…
READ MORE
BioFluidica Exhibits at ASCO 2023
Chicago, IL, June 3-5, 2023 BioFluidica received a record number of visitors at Booth 27172 at the ASCO 2023 Annual…
READ MORE
Assessing Breast Cancer Molecular Subtypes Using Extracellular Vesicles’ (EVs’) mRNA
Hu et al., Anal. Chem. 2023 May 16;95(19) 7665-7675 used LiquidScan to affinity capture EVs from plasma of breast cancer…
READ MORE
BioFluidica Exhibits at AACR 2023, Orlando, FL
The BioFluidica booth at the recent American Association for Cancer Research, AACR, Annual Conference experienced much attention as scientists learned…
READ MORE
HER2+ Breast Cancer Pilot Study
Blood was drawn from 16 breast cancer patients and enriched for Circulating Tumor Cells (CTCs) using LiquidScan. Isolated cells were…
READ MORE
BioFluidica Exhibits and Presents at PMWC 2023 in Santa Clara, CA
BioFluidica attended the Precision Medicine World Conference (PMWC) 2023 on January 25-27th. Every year PMWC gathers top researchers and medical…
READ MORE
Liquid Biopsies Take Center Stage at 2022 ASCO Annual Meeting
BioFluidica presented its LiquidScan, a microfluidic chip that searches a blood sample for rare biomarkers such as CTCs (circulating tumor…
READ MORE
BioFluidica turns to blood for accurate, inexpensive cancer tests
San Diego Union Tribune | By Bradley J. Fikes, August 31, 2018 Blood is hard to beat for detecting disease. This…
READ MORE